Search Within

Jaclyn Frances Hechtman

  1. "2016"
Formats
  1. Meeting Abstract (23)
  2. Journal Article (7)
Groups
  1. Department of Pathology and Laboratory Medicine (28)
  2. Department of Medicine (23)
  3. Solid Tumor Oncology Division (23)
  4. GSK Faculty (21)
  5. Human Oncology and Pathogenesis Program (21)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (19)

More Groups

People
  1. Efsevia Vakiani (19)
  2. Jinru Shia (18)
  3. Michael Berger (15)
  4. David Klimstra (13)
  5. Ahmet Zehir (9)
  6. Lik Hang Lee (8)

More People

Years
  1. 2016 (30)
Publications
  1. Journal of Clinical Oncology (9)
  2. Modern Pathology (7)
  3. Laboratory Investigation (6)
  4. Annals of Oncology (3)
  5. Clinical Cancer Research (1)
  6. Human Pathology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (9)
  2. Nature Research (7)
  3. Nature Publishing Group (6)
  4. Oxford University Press (3)
  5. American Association for Cancer Research (2)
  6. Elsevier Inc. (1)

More Publishers

Results (30)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Next-generation sequencing (NGS) in advanced well differentiated pancreatic neuroendocrine tumors (WD pNETs): A study using MSK-IMPACT
    Meeting Abstract

    Raj, N. P.; Soumerai, T.; Valentino, E.; Hechtman, J. F.; Berger, M. F.; Reidy, D. L.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Comprehensive molecular profiling and analysis of mutual exclusivity of genetic aberrations (MEGA) of intra- and extrahepatic cholangiocarcinomas (IHC and EHC) evaluation of prognostic features and potential targets for intervention
    Meeting Abstract

    Lowery, M. A.; Ptashkin, R.; Jordan, E.; Berger, M. F.; Zehir, A.; Kemeny, N. E.; O'Reilly, E. M.; Jarnagin, W. R.; Harding, J. J.; DeMatteo, R. P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Genomic profiling of pancreas ductal adenocarcinoma (PDA), actionability, and correlation with clinical phenotype
    Meeting Abstract

    Jordan, E.; Lowery, M. A.; Ptashkin, R.; Zehir, A.; Berger, M. F.; Maynard, H.; Glassman, D. C.; Covington, C. M.; Schultz, N.; Abou-Alfa, G. K.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Emergence of RTK/RAS/PI3K pathway alterations in trastuzumab-refractory HER2-positive esophagogastric (EG) tumors
    Meeting Abstract

    Janjigian, Y. Y.; Sanchez-Vega, F.; Tuvy, Y.; Bouvier, N.; Riches, J. C.; Margolis, M.; Millang, B. M.; Scott, S. N.; Kundra, R.; Castel, P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Somatic tumor profiling of DNA mismatch repair deficient (MMR-D) colorectal cancers (CRC)
    Meeting Abstract

    Ganesh, K.; Middha, S.; Hechtman, J. F.; Ashraf, A.; Tran, C.; Villano, D.; Yaeger, R. D.; Segal, N. H.; Cercek, A.; Varghese, A. M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Correlation between comprehensive molecular profiling and clinical outcomes in patients with colorectal liver metastases
    Meeting Abstract

    Connell, L. C.; Sanchez-Vega, F.; Boucher, T. M.; Yaeger, R. D.; Schultz, N.; Cercek, A.; Hechtman, J. F.; Kemeny, N. E.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Clinical next generation sequencing (NGS) of esophagogastric (EG) adenocarcinomas identifies distinct molecular signatures of response to HER2 inhibition, first-line 5FU/platinum and PD1/CTLA4 blockade
    Meeting Abstract

    Janjigian, Y. Y.; Sanchez-Vega, F.; Jonsson, P.; Tuvy, Y.; Bouvier, N.; Riches, J.; Kundra, R.; Ku, G.; Hechtman, J. F.; Kelsen, D.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of patients with metastatic colorectal cancer (CRC) harboring NRAS mutations
    Meeting Abstract

    Braghiroli, M. I.; Chou, J. F.; Hechtman, J. F.; Capanu, M.; Cercek, A.; Yaeger, R.
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Chromosome 20q gain defines a molecular subtype associated with microsatellite stability, wild-type RAS/RAF, mutant TP53, left-sided tumors, and better overall survival in metastatic colorectal carcinoma
    Meeting Abstract

    Ptashkin, R. N.; Pagan, C.; Middha, S.; Yaeger, R.; Ladanyi, M.; Berger, M.; Zehir, A.; Hechtman, J. F.
    Journal of Molecular Diagnostics (2016)

    Fulltext@MSK | Save
  • Patterns and prognostic relevance of PD-1 and PD-L1 expression in colorectal carcinoma
    Journal Article

    Lee, L. H.; Cavalcanti, M. S.; Segal, N. H.; Hechtman, J. F.; Weiser, M. R.; Smith, J. J.; Garcia-Aguilar, J.; Sadot, E.; Ntiamoah, P.; Markowitz, A. J.; more...
    Modern Pathology (2016)

    Fulltext@MSK | Save